Amneal Pharmaceuticals Newsroom

Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating

Moomoo NewsNov 21 07:34 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaNov 11 08:37 ET

Piper Sandler Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsNov 11 07:31 ET

Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 11 03:32 ET

Barclays Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)

TipRanksNov 11 03:11 ET

Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 7 03:33 ET

Amneal Pharmaceuticals (AMRX) Receives a Buy From Barclays

TipRanksNov 7 03:18 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaOct 2 09:08 ET

Truist Financial Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Announces Target Price $12

Moomoo NewsOct 2 07:36 ET

Amneal Pharmaceuticals (AMRX) Gets a Buy From Truist Financial

TipRanksOct 2 07:10 ET

J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Hold Rating, Maintains Target Price $9

Moomoo NewsSep 12 08:32 ET

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Aura Biosciences Inc (AURA) and Terns Pharmaceuticals (TERN)

TipRanksSep 12 08:27 ET

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 08:42 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaSep 6 08:11 ET

J.P. Morgan Initiates Amneal Pharmaceuticals(AMRX.US) With Hold Rating, Announces Target Price $9

Moomoo NewsSep 6 05:32 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaAug 13 08:52 ET

Barclays Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsAug 13 05:33 ET

Amneal Pharmaceuticals (AMRX) Gets a Buy From Barclays

TipRanksAug 13 04:51 ET

Amneal Pharmaceuticals Analyst Ratings

BenzingaAug 12 08:50 ET

Truist Adjusts Price Target on Amneal Pharmaceuticals to $10 From $9, Maintains Buy Rating

MT NewswiresAug 12 05:43 ET